Smiths Medical ASD, Inc. recalls G1777: Umbilical (2) 3 mL Line Draw, Luer lock syringes (heparin concentration: 23.5 I.U. per mL) with Filter-Pro¿ devi

Recalled March 19, 2014 · FDA recall Z-1191-2014 · Smiths Medical ASD

Hazard

issue with the plunger tip of the Portex¿ Arterial Blood Sampling Line Draw Syringes · FDA Class II

Units

N/A

Sold at

Worldwide Distribution - USA including AL, AZ, CA, CO, CT, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV. Internationally to Australia, Austria, Belgium, Belize, Brazil, Canada, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Netherlands, Norway, Poland, Scotland, Spain, and Sweden.

Description

issue with the plunger tip of the Portex¿ Arterial Blood Sampling Line Draw Syringes

Product

G1777: Umbilical (2) 3 mL Line Draw, Luer lock syringes (heparin concentration: 23.5 I.U. per mL) with Filter-Pro¿ devices and (2) Needle-Pro¿ Devices with 22G x 1¿needles Arterial Blood Sampling Line Draw Syringes are sterile, single-use devices, in-vitro diagnostic devices used for the drawing of arterial blood via an arterial line. The product is not for injection.

Manufacturer(s)

Smiths Medical ASD, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →